Citius Oncology annual shares outstanding
2021
2022
2022
2023
2023
2024
2025
Citius Oncology Shares Outstanding History (CTOR)
Citius Oncology reported 83.5M shares outstanding at the end of fiscal 2025.
View full Citius Oncology company overviewCitius Oncology annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 83.5M | 12.0M | +16.72% |
| 2024 | 2024-09-30 | 71.6M | 4.1M | +6.00% |
| 2023 · Dec 31 | 2023-12-31 | 2.3M | −75,000 | −3.10% |
| 2023 · Sep 30 | 2023-09-30 | 67.5M | −3.7M | −5.25% |
| 2022 | 2022-12-31 | 2.4M | 0 | 0.00% |
| 2022 | 2022-09-30 | 71.2M | — | — |
| 2021 | 2021-12-31 | 2.4M | — | — |
Citius Oncology quarterly shares outstanding
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q4.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 105.8M | 34.2M | +47.81% |
| Q2 2026 | 2026-03-31 | 93.0M | 21.4M | +29.95% |
| Q1 2026 | 2025-12-31 | 84.8M | 13.2M | +18.51% |
| Q4 2025 | 2025-09-30 | 83.5M | 12.0M | +16.72% |
| Q3 2025 | 2025-06-30 | 71.6M | 69.2M | +2956.49% |
| Q2 2025 | 2025-03-31 | 71.6M | 69.2M | +2956.49% |
| Q1 2025 | 2024-12-31 | 71.6M | 69.2M | +2956.49% |
| Q4 2024 | 2024-09-30 | 71.6M | 4.1M | +6.00% |
| Q2 2024 | 2024-06-30 | 2.3M | −75,000 | −3.10% |
| Q1 2024 | 2024-03-31 | 2.3M | −75,000 | −3.10% |
| Q4 2023 · Dec 31 | 2023-12-31 | 2.3M | −75,000 | −3.10% |
| Q4 2023 · Sep 30 | 2023-09-30 | 67.5M | 65.8M | +3813.04% |
| Q2 2023 | 2023-06-30 | 2.4M | — | — |
| Q1 2023 | 2023-03-31 | 2.4M | — | — |
| Q4 2022 | 2022-12-31 | 2.4M | 0 | 0.00% |
| Q3 2022 | 2022-09-30 | 1.7M | — | — |
| Q4 2021 | 2021-12-31 | 2.4M | — | — |
Citius Oncology shares outstanding trends
Between the periods ended 2021-12-31 and 2025-09-30, Citius Oncology's shares outstanding moved from 2.4M to 83.5M, a change of 81.1M. The latest reported quarter, Q3 2026, shows 105.8M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Citius Oncology source filings ↗Community posts
Citius Oncology’s wholesaler shipments rise sharply while institutional orders grow modestly
Citius Oncology ($CTOR) reported preliminary sales of 792 Lymphir units to US wholesalers for its fiscal fourth quarter of 2026, up 120% from 360 in the preceding quarter. Separately, prescribing centers ordered 950 vials from wholesalers, ...
